FDA’s Win-Win: More Comprehensive IND Safety Reports With Minimal Effort Due To Harmonization

 
• By Sarah Karlin-Smith
  
Globe
FDA proposal would harmonize US IND reports with international community • Source: Shutterstock

More from Clinical Trials

More from R&D